Task: Answer the multiple choice question.
Question: Which compound exhibits a 6.981\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
b COc1ccc(/C=C(/NC(=O)c2ccc(OC)c(OC)c2)C(=O)NCCCn2ccnc2)cc1
c O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C1CC(c2ccc(C(F)(F)F)cc2)=NO1
Answer: a. FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
FC(F)(F)c1ccc2c(c1)NP(=S)(N1CCOCC1)c1nccn1-2
4-[4-sulfanylidene-7-(trifluoromethyl)-5H-imidazo[2,1-c][1,4,2]benzodiazaphosphinin-4-yl]morpholine